View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Infection News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 07, 2024
4 min read
Save

Q&A: Illicit fentanyl use raises hepatitis C risk among injection drug users

Q&A: Illicit fentanyl use raises hepatitis C risk among injection drug users

A new study provides the first evidence that illicit fentanyl use may play a role in hepatitis C transmission among injection drug users, according to researchers.

SPONSORED CONTENT
August 02, 2024
2 min read
Save

Vonoprazan-bismuth triple therapy eradicates H. pylori in up to 90.9% vs. standard care

Vonoprazan-bismuth triple therapy eradicates <i>H. pylori</i> in up to 90.9% vs. standard care

A triple therapy of vonoprazan, amoxicillin and bismuth potassium citrate achieved an eradication rate of just over 90%, similar to that of the standard quadruple therapy, in patients with Helicobacter pylori infection, according to data.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
July 26, 2024
4 min read
Save

‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’

&lsquo;It&rsquo;s time for action&rsquo;: World Hepatitis Day calls to end an &lsquo;entirely preventable disease&rsquo;

Every year on July 28th, clinicians and researchers recognize World Hepatitis Day to bring awareness to one of the world’s deadliest but preventable viruses and continue efforts to meet the global goal of eliminating viral hepatitis by 2030

SPONSORED CONTENT
July 22, 2024
2 min read
Save

Tenofovir alafenamide maintains virological control in HBV with renal, hepatic impairment

Tenofovir alafenamide maintains virological control in HBV with renal, hepatic impairment

Tenofovir alafenamide was safe and maintained virological response in patients with chronic hepatitis B virus infection and renal or hepatic impairment who switched from tenofovir disoproxil fumarate or other antivirals, according to data.

SPONSORED CONTENT
July 17, 2024
2 min read
Save

Q&A: Risk for long COVID has declined, remains ‘substantial’

Q&amp;A: Risk for long COVID has declined, remains &lsquo;substantial&rsquo;

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

SPONSORED CONTENT
July 11, 2024
2 min read
Save

Untreated irrigation water linked to 2023 E. coli outbreak among 13 Utah children

Untreated irrigation water linked to 2023 <i>E. coli</i> outbreak among 13 Utah children

A 2023 outbreak of Shiga toxin-producing Escherichia coli O157:H7 involving at least 13 children in Utah was linked to untreated municipal irrigation water, according to a CDC investigation published in Morbidity and Mortality Weekly Report.

SPONSORED CONTENT
June 28, 2024
2 min read
Save

Individuals with high genetic risk for gastric cancer may benefit from H. pylori treatment

Individuals with high genetic risk for gastric cancer may benefit from <i>H. pylori</i> treatment

Treatment for Helicobacter pylori infection was associated with reduced risk for gastric cancer among patients with a high genetic risk, suggesting that chemoprevention should be personalized to genetic risk, according to data.

SPONSORED CONTENT
June 25, 2024
2 min read
Save

Comprehensive norovirus response successfully ended outbreak

Comprehensive norovirus response successfully ended outbreak

SAN ANTONIO — After confirming reports of norovirus in a hematologic oncology and clinical trials unit, a comprehensive infection prevention plan was put in place, stopping further infections with no recurrence.

SPONSORED CONTENT
June 05, 2024
1 min read
Save

Recalled cucumbers may be cause of ongoing Salmonella outbreak

Recalled cucumbers may be cause of ongoing <i>Salmonella</i> outbreak

The CDC on Wednesday announced that recalled cucumbers have been identified as the potential cause of an ongoing Salmonella outbreak.

SPONSORED CONTENT
May 23, 2024
7 min watch
Save

VIDEO: Real-world data confirm Rebyota’s ‘consistent’ efficacy in recurrent C. difficile

VIDEO: Real-world data confirm Rebyota&rsquo;s &lsquo;consistent&rsquo; efficacy in recurrent <i>C. difficile</i>

WASHINGTON — In a Healio video exclusive, Paul Feuerstadt, MD, FACG, AGAF, discusses real-world results for Rebyota as a treatment of recurrent Clostridioides difficile infection, which were presented at Digestive Disease Week.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails